Work

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

Year: 2010

Type: article

Study design: Study Protocol

Source: American Heart Journal

DOI: 10.1016/j.ahj.2010.06.042

Authors: Christian T. Ruff, Robert P. Giugliano, Elliott M. Antman, Sharon E. Crugnale, Tomas Bocanegra, Michele Mercuri, James Hanyok, Indravadan Patel, Minggao Shi, Dan Salazar, Carolyn H. McCabe, Eugene Braunwald

Institutions: Brigham and Women's Hospital, Harvard University, Thrombolysis in Myocardial Infarction Study Group, Daiichi Sankyo (United States)

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1965320794

FWCI: 48.38

Cites: 28

Cited by: 476

Related to: 8